Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000172

2. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   МақолаCAR-T cell therapy researchHeliyon20241 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.102962

3. Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

   Minzhi Huang, Ahmad Ewadi, Nazli Servatian +6

   Шарҳ мақолаCRISPR and Genetic EngineeringCritical Reviews in Oncology/Hematology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000099